Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

AAAAI news: BM-144 as a new lead TxA2 antagonist molecule for asthma, thrombosis

March 7, 2000

Tyrosine kinase inhibitor D-58 is a potent antiallergic, antiinflammatory agent

March 7, 2000

Modulators of CCR5 receptor and their use presented by SmithKline Beecham

March 7, 2000

Rupatadine inhibits TNF-alpha release, may have potential in late-phase allergic reactions

March 6, 2000

Exploratory human studies with PNU-142731A reported at AAAAI meeting

March 6, 2000

Phase I/II trial examines multiple doses of IL-4R in asthmatic patients

March 6, 2000

AAAAI news: icatibant effective in reducing antigen-induced nasal hyperresponsiveness in SAR

March 6, 2000

NicOx presents nitrate salts of respiratory medications with improved tolerance

March 6, 2000

EpiGenesis and Taisho sign binding letter of intent for EPI-2010

March 3, 2000

FDA approves new Allegra formulations

March 1, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Latus Bio series A financing supports early-stage programs
BioWorld Science
Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...